This is a Pilot Study Which Aims to Assess the Validity and Applicability of Lateral Flow Assays (LFAs) Which Can be Used as a Point of Care Test for COVID-19
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19 (NCT04629157) | Alder Hey Children's NHS Foundation Trust | 2020-11-05 |
Track This is a Pilot Study Which Aims to Assess the Validity and Applicability of Lateral Flow Assays (LFAs) Which Can be Used as a Point of Care Test for COVID-19 automatically
Every clearance here is in the API, with alerts when new ones post.